Reply to: “Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia—The SPASTOX Trial”
Sign Up to like & getrecommendations! Published in 2021 at "Movement Disorders"
DOI: 10.1002/mds.28658
Abstract: We cordially thank Nonnekes and colleagues for emphasizing the scientific importance of the SPASTOX trial. Likewise, we appreciate the perspectives raised in this letter and the opportunity to highlight and discuss some of the lessons… read more here.
Keywords: trial; toxin type; hereditary spastic; spastox trial ... See more keywords